The phenotype of newly diagnosed Graves' disease in Italy in recent years is milder than in the past: results of a large observational longitudinal study.

Abstract

The Merseburg triad (hyperthyroidism, goiter, and orbitopathy) characterizes classical description of Graves' disease (GD). Aim of this observational, longitudinal study was to evaluate the current clinical features of newly diagnosed GD in Italy. In two Northern Italy centers (Varese and Pavia), 283 consecutive patients (211 women, 72 men; mean age 47.4years) with newly diagnosed GD were recruited in the years 2010-2014. Diagnosis was based on established criteria, and thyroid volume was assessed by ultrasonography. A clinical severity score (CSS) to assess the overall disease severity was developed by grading each component of the Merseburg triad. At diagnosis, 45% of patients had no goiter, and 30% had a small goiter. The proportion of goitrous patients was much lower than in two Italian studies performed 20-30years ago. Hyperthyroidism was subclinical in 16% and mild in 29% of patients, and Graves' orbitopathy was present in 20%, usually mild, and active in only 2.5% of patients. Using the CSS, less than half (44%) of the patients had severe GD, while 22% had mild and 34% moderate disease. CSS was associated with a significantly higher risk of poorly controlled hyperthyroidism at 6months. In Italy, a relevant proportion of Graves' patients at diagnosis have mild to moderate GD; about half of them have no goiter, slightly less than one-fifth have subclinical hyperthyroidism, and only 20% have GO. Thus, the clinical phenotype of GD is milder than in the past, possibly due to both earlier diagnosis and treatment, and improved iodine nutrition.